Q4 2024 Earnings Call Transcript February 10, 2025 Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $3.98 EPS, expectations were $4.02. Operator: Good day, and ...

Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...

Operator Good day, and welcome to the Vertex Pharmaceuticals fourth quarter 2024 earnings call. All participants will be in a ...

Life Science Washington, the state’s life sciences industry association, announced the expansion of its board of directors with the ad ...

Fenaux was most recently head of intercontinental region at Bristol-Myers Squibb. He made no comment about whether his appointment will result in a change of approach from Vertex in the UK.

The Middle East and Africa (MEA) region is at the forefront of a global renewable energy transformation, and leading this ...

The ASX retreated from earlier gains and closed 0.25% lower on Tuesday, following a late-day tumble in pharma giant CSL ...

Law firm Bermans has made three strategic hires to bolster its litigation, asset-based lending recoveries and private client ...

The 988 line was supposed to anchor a crisis system that gave people “someone to call, someone to come, somewhere to go.” It hasn't happened.

S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication. 1,2 Furthermore, this drug has received ...